Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-lysine 6-oxidase activity	LOXL4 LOXL3	7.41e-05	5	55	2	GO:0004720
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	KAT6A KAT6B	2.65e-04	9	55	2	GO:0036408
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	KAT6A KAT6B	7.64e-04	15	55	2	GO:0010484
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	LOXL4 LOXL3	8.72e-04	16	55	2	GO:0016641
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	LOXL4 LOXL3	1.37e-03	20	55	2	GO:0016638
GeneOntologyMolecularFunction	endopeptidase inhibitor activity	HMSD SERPINB7 GBP2 PAPLN	1.52e-03	180	55	4	GO:0004866
GeneOntologyMolecularFunction	peptidase inhibitor activity	HMSD SERPINB7 GBP2 PAPLN	1.75e-03	187	55	4	GO:0030414
GeneOntologyCellularComponent	MOZ/MORF histone acetyltransferase complex	KAT6A KAT6B	1.36e-04	7	54	2	GO:0070776
GeneOntologyCellularComponent	H3 histone acetyltransferase complex	KAT6A KAT6B	1.82e-04	8	54	2	GO:0070775
Domain	Lysyl_oxidase	LOXL4 LOXL3	8.16e-05	5	54	2	IPR001695
Domain	MOZ_SAS	KAT6A KAT6B	8.16e-05	5	54	2	PF01853
Domain	HAT_MYST-type	KAT6A KAT6B	8.16e-05	5	54	2	IPR002717
Domain	LYSYL_OXIDASE	LOXL4 LOXL3	8.16e-05	5	54	2	PS00926
Domain	Lysyl_oxidase_CS	LOXL4 LOXL3	8.16e-05	5	54	2	IPR019828
Domain	Lysyl_oxidase	LOXL4 LOXL3	8.16e-05	5	54	2	PF01186
Domain	MYST_HAT	KAT6A KAT6B	8.16e-05	5	54	2	PS51726
Domain	Znf_MYM	ZMYM1 ZMYM4	1.71e-04	7	54	2	IPR010507
Domain	zf-FCS	ZMYM1 ZMYM4	1.71e-04	7	54	2	PF06467
Domain	TRASH_dom	ZMYM1 ZMYM4	2.27e-04	8	54	2	IPR011017
Domain	TRASH	ZMYM1 ZMYM4	2.27e-04	8	54	2	SM00746
Domain	H15	KAT6A KAT6B	6.27e-04	13	54	2	SM00526
Domain	H15	KAT6A KAT6B	6.27e-04	13	54	2	PS51504
Domain	Histone_H1/H5_H15	KAT6A KAT6B	7.30e-04	14	54	2	IPR005818
Domain	Znf_FYVE_PHD	ANKFY1 KAT6A KAT6B FGD6	8.58e-04	147	54	4	IPR011011
Domain	SRCR	LOXL4 LOXL3	1.66e-03	21	54	2	PF00530
Domain	Lectin_C	DGCR2 REG4 ATRNL1	1.84e-03	84	54	3	PF00059
Domain	CLECT	DGCR2 REG4 ATRNL1	1.84e-03	84	54	3	SM00034
Domain	C_TYPE_LECTIN_2	DGCR2 REG4 ATRNL1	1.91e-03	85	54	3	PS50041
Domain	C-type_lectin-like	DGCR2 REG4 ATRNL1	1.97e-03	86	54	3	IPR001304
Domain	Spectrin	DST SPTA1	2.00e-03	23	54	2	PF00435
Domain	SR	LOXL4 LOXL3	2.36e-03	25	54	2	SM00202
Domain	-	LOXL4 LOXL3	2.36e-03	25	54	2	3.10.250.10
Domain	SRCR_1	LOXL4 LOXL3	2.55e-03	26	54	2	PS00420
Domain	SRCR_2	LOXL4 LOXL3	2.55e-03	26	54	2	PS50287
Domain	SRCR-like_dom	LOXL4 LOXL3	2.55e-03	26	54	2	IPR017448
Domain	SRCR	LOXL4 LOXL3	2.75e-03	27	54	2	IPR001190
Domain	-	DGCR2 REG4 ATRNL1	2.78e-03	97	54	3	3.10.100.10
Domain	C-type_lectin-like/link	DGCR2 REG4 ATRNL1	2.95e-03	99	54	3	IPR016186
Domain	FYVE	ANKFY1 FGD6	3.17e-03	29	54	2	PF01363
Domain	FYVE	ANKFY1 FGD6	3.17e-03	29	54	2	SM00064
Domain	Spectrin_repeat	DST SPTA1	3.17e-03	29	54	2	IPR002017
Domain	Ank_2	ANKFY1 ASB9 ANKRD30B OSTF1	3.44e-03	215	54	4	PF12796
Domain	CTDL_fold	DGCR2 REG4 ATRNL1	3.67e-03	107	54	3	IPR016187
Domain	Spectrin/alpha-actinin	DST SPTA1	3.85e-03	32	54	2	IPR018159
Domain	SPEC	DST SPTA1	3.85e-03	32	54	2	SM00150
Domain	Ank	ANKFY1 ASB9 ANKRD30B OSTF1	4.24e-03	228	54	4	PF00023
Domain	Znf_FYVE-rel	ANKFY1 FGD6	4.34e-03	34	54	2	IPR017455
Domain	Serpin_dom	HMSD SERPINB7	4.85e-03	36	54	2	IPR023796
Domain	SERPIN	HMSD SERPINB7	5.12e-03	37	54	2	PS00284
Domain	Znf_FYVE	ANKFY1 FGD6	5.40e-03	38	54	2	IPR000306
Domain	Serpin	HMSD SERPINB7	5.40e-03	38	54	2	PF00079
Domain	Serpin_fam	HMSD SERPINB7	5.68e-03	39	54	2	IPR000215
Domain	-	ANKFY1 ASB9 ANKRD30B OSTF1	5.71e-03	248	54	4	1.25.40.20
Domain	ANK	ANKFY1 ASB9 ANKRD30B OSTF1	5.95e-03	251	54	4	SM00248
Domain	LDLR_class-A_CS	DGCR2 LRP1B	5.97e-03	40	54	2	IPR023415
Domain	-	KAT6A KAT6B	5.97e-03	40	54	2	3.40.630.30
Domain	ZF_FYVE	ANKFY1 FGD6	5.97e-03	40	54	2	PS50178
Domain	ANK_REPEAT	ANKFY1 ASB9 ANKRD30B OSTF1	6.12e-03	253	54	4	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKFY1 ASB9 ANKRD30B OSTF1	6.20e-03	254	54	4	IPR020683
Domain	ANK_REP_REGION	ANKFY1 ASB9 ANKRD30B OSTF1	6.20e-03	254	54	4	PS50297
Domain	Ankyrin_rpt	ANKFY1 ASB9 ANKRD30B OSTF1	6.91e-03	262	54	4	IPR002110
Domain	Acyl_CoA_acyltransferase	KAT6A KAT6B	7.50e-03	45	54	2	IPR016181
Domain	Ldl_recept_a	DGCR2 LRP1B	7.50e-03	45	54	2	PF00057
Domain	-	DGCR2 LRP1B	7.83e-03	46	54	2	4.10.400.10
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WDR19 TET2 SMG1 DGCR2 ARID1B DST CECR2 FAM53B AKAP11 CEP126 KAT6B ZMYM4 SMG6	1.63e-12	529	55	13	14621295
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARFGEF3 TET2 DST KIAA1217 FAM53B AKAP11 NSMCE2 CDC25C FGD6 DOP1A MPRIP	8.90e-08	861	55	11	36931259
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 ANKFY1 DST AKAP11 KAT6B SMG6	1.53e-06	225	55	6	12168954
Pubmed	ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B.	KAT6A KAT6B	2.46e-06	2	55	2	39505971
Pubmed	Regulation of KAT6 Acetyltransferases and Their Roles in Cell Cycle Progression, Stem Cell Maintenance, and Human Disease.	KAT6A KAT6B	2.46e-06	2	55	2	27185879
Pubmed	The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification.	KAT6A KAT6B	2.46e-06	2	55	2	24150941
Pubmed	MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain.	KAT6A KAT6B	7.36e-06	3	55	2	36754959
Pubmed	Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities.	LOXL4 LOXL3	7.36e-06	3	55	2	19015874
Pubmed	Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin.	KAT6A KAT6B	7.36e-06	3	55	2	23063713
Pubmed	Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.	LOXL4 LOXL3	7.36e-06	3	55	2	30045039
Pubmed	Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).	KAT6A KAT6B	1.47e-05	4	55	2	21880731
Pubmed	The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60.	KAT6A KAT6B	1.47e-05	4	55	2	17980166
Pubmed	Structural and functional diversity of lysyl oxidase and the LOX-like proteins.	LOXL4 LOXL3	1.47e-05	4	55	2	12686136
Pubmed	Tagging genes with cassette-exchange sites.	UBR4 ZMYM1 NSMCE2 KAT6B ZMYM4 SMG6	1.49e-05	335	55	6	15741177
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ARFGEF3 ARID1B ANKFY1 KIAA1217	2.20e-05	103	55	4	10574462
Pubmed	Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.	KAT6A KAT6B	2.45e-05	5	55	2	17182677
Pubmed	MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.	KAT6A KAT6B	2.45e-05	5	55	2	11965546
Pubmed	Common polymorphisms in human lysyl oxidase genes are not associated with the adolescent idiopathic scoliosis phenotype.	LOXL4 LOXL3	2.45e-05	5	55	2	21740577
Pubmed	Characterization of human Smg5/7a: a protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1.	SMG1 SMG6	3.67e-05	6	55	2	12554878
Pubmed	Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay.	SMG1 SMG6	3.67e-05	6	55	2	25770585
Pubmed	Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms.	LOXL4 LOXL3	3.67e-05	6	55	2	17287949
Pubmed	Next-generation sequencing identifies the Danforth's short tail mouse mutation as a retrotransposon insertion affecting Ptf1a expression.	ARMC3 KIAA1217	3.67e-05	6	55	2	23437000
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	ARMC3 ATRNL1 LOXL4 TACR2 ABCC2 KAT6B	4.93e-05	415	55	6	16385451
Pubmed	Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.	KAT6A KAT6B	5.13e-05	7	55	2	18794358
Pubmed	Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends.	SMG1 SMG6	5.13e-05	7	55	2	17916692
Pubmed	Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7.	SMG1 SMG6	5.13e-05	7	55	2	14636577
Pubmed	A protein interaction landscape of breast cancer.	ARID1B DST UBR4 LOXL4 ZMYM1 RBM28 MPRIP	6.15e-05	634	55	7	34591612
Pubmed	CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos.	SMG1 SMG6	6.83e-05	8	55	2	36563685
Pubmed	Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.	LOXL4 LOXL3	6.83e-05	8	55	2	19458888
Pubmed	Human transcription factor protein interaction networks.	TET2 SMG1 ARID1B DST UBR4 ZMYM1 RBM28 ZMYM4 GATAD2B MPRIP	7.19e-05	1429	55	10	35140242
Pubmed	The human RNA surveillance factor UPF1 is required for S phase progression and genome stability.	SMG1 SMG6	8.78e-05	9	55	2	16488880
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ARFGEF3 KIAA1217 KAT6A OSTF1 NSMCE2 KAT6B ARHGAP8 ZMYM4 DOP1A SMG6	1.01e-04	1489	55	10	28611215
Pubmed	TGF-beta1 induces the different expressions of lysyl oxidases and matrix metalloproteinases in anterior cruciate ligament and medial collateral ligament fibroblasts after mechanical injury.	LOXL4 LOXL3	1.10e-04	10	55	2	23357697
Pubmed	Acetylation of HIV-1 integrase by p300 regulates viral integration.	KAT6A KAT6B	1.34e-04	11	55	2	16096645
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ANKFY1 DST KIAA1217 LGSN ZMYM4 SMG6	1.57e-04	513	55	6	25798074
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	WDR19 TET2 DST ATRNL1 UBR4 NAV3 LRP1B ZMYM4 MPRIP	1.71e-04	1285	55	9	35914814
Pubmed	A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.	TET2 CECR2	1.89e-04	13	55	2	26989192
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	ATRNL1 KIAA1217 CRB1	1.98e-04	71	55	3	33541421
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ARID1B UBR4 RBM28 KAT6B GATAD2B	2.05e-04	341	55	5	32971831
Pubmed	Loss of Lysyl Oxidase-like 3 Attenuates Embryonic Lung Development in Mice.	LOXL4 LOXL3	2.54e-04	15	55	2	27645581
Pubmed	Functional proteomics mapping of a human signaling pathway.	SMG1 DGCR2 ARID1B DST UBR4 GATAD2B	3.36e-04	591	55	6	15231748
Pubmed	The RNA helicase DHX34 activates NMD by promoting a transition from the surveillance to the decay-inducing complex.	SMG1 SMG6	3.70e-04	18	55	2	25220460
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TET2 ARID1B CECR2 ZMYM1 GATAD2B	4.16e-04	398	55	5	35016035
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 ANKFY1 DST UBR4 ZMYM4	5.20e-04	418	55	5	34709266
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SMG1 KIAA1217 CDC25C ZMYM4 DOP1A	5.31e-04	420	55	5	28065597
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	SMG1 ANKFY1 DST AKAP11 OSTF1 GATAD2B MPRIP	5.58e-04	910	55	7	36736316
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	TET2 SPTA1 RBM28 KAT6B	7.61e-04	259	55	4	30404004
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANKFY1 DST KIAA1217 UBR4 GATAD2B MPRIP SMG6	7.79e-04	963	55	7	28671696
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SMG1 ARID1B ANKFY1 DST ZMYM4	1.13e-03	497	55	5	23414517
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 KIAA1217 PTCD2 KAT6B SMG6	1.57e-03	536	55	5	15840001
Cytoband	10p12.31	ARMC3 KIAA1217	3.21e-04	22	55	2	10p12.31
Cytoband	6p12.1	TINAG DST	7.27e-04	33	55	2	6p12.1
Cytoband	10q24	LOXL4 ABCC2	8.17e-04	35	55	2	10q24
Cytoband	1p34.3	C1orf216 ZMYM1	2.54e-03	62	55	2	1p34.3
Cytoband	17p13.3	ANKFY1 SMG6	5.05e-03	88	55	2	17p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1p34	C1orf216 ZMYM1 ZMYM4	5.33e-03	294	55	3	chr1p34
GeneFamily	Zinc fingers MYM-type	ZMYM1 ZMYM4	5.75e-05	6	36	2	86
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	DGCR2 REG4 ATRNL1	7.34e-05	41	36	3	1298
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A KAT6B	4.55e-04	16	36	2	66
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT6A KAT6B	5.14e-04	17	36	2	486
GeneFamily	Ankyrin repeat domain containing	ANKFY1 ASB9 ANKRD30B OSTF1	1.32e-03	242	36	4	403
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	ANKFY1 FGD6	1.73e-03	31	36	2	81
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ARFGEF3 AKAP11 CDC25C	5.53e-03	181	36	3	694
GeneFamily	PHD finger proteins	KAT6A KAT6B	1.38e-02	90	36	2	88
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	DGCR2 DST KAT6B LRP1B MPRIP	2.64e-06	177	55	5	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1 CEP126	4.24e-06	195	55	5	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1 CEP126	4.24e-06	195	55	5	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1 CEP126	4.24e-06	195	55	5	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1 CEP126	4.35e-06	196	55	5	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARFGEF3 ARMC3 RP1 CEP126 LGSN	4.68e-06	199	55	5	92fdf6e2f0786ab2ab78126e9131a93794168139
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.37e-05	148	55	4	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.37e-05	148	55	4	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	C1orf216 CDC25C LRP1B DOP1A	3.45e-05	149	55	4	7e295b2b82dea0754e98f8cef788e2781e5d641f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	C1orf216 CDC25C LRP1B DOP1A	3.45e-05	149	55	4	b4f77dc5f9d08b249fe5cd9a0acf86308c528ef4
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|356C / Donor, Lineage, Cell class and subclass (all cells)	SMG1 SPTA1 CDC25C CRB1	3.55e-05	150	55	4	6bdf9df586f348641a25a445e83a41e47e7f347e
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma\|TCGA-Uterus / Sample_Type by Project: Shred V9	ARFGEF3 TET2 DST FGD6	3.64e-05	151	55	4	2810bfa01bd3016aeba29735eb4a9284792e8aac
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.64e-05	151	55	4	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.64e-05	151	55	4	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	Ciliated_cells-A-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 ATRNL1 CEP126 LRRC9	3.93e-05	154	55	4	3b938e23324f7edb56797b4a76fb96ff588142cf
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.93e-05	154	55	4	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	3.93e-05	154	55	4	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	4.03e-05	155	55	4	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 RP1 CEP126 LRRC9	4.03e-05	155	55	4	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Cbln2-Kcnh8_(Deep_layer_subiculum)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TINAG PAPLN TACR2	4.34e-05	55	55	3	5ce0008811bb696191923de9b34ea6e0d8d39a7a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARFGEF3 CECR2 RP1 LRP1B	4.67e-05	161	55	4	4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARMC3 RP1 LGSN LRRC9	5.14e-05	165	55	4	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARMC3 RP1 LGSN LRRC9	5.14e-05	165	55	4	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARFGEF3 CECR2 KIAA1217 FGD6	5.26e-05	166	55	4	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RP1 CEP126 LRRC9	5.64e-05	169	55	4	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Ciliated_cells-A-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 RP1 CEP126 LGSN	5.77e-05	170	55	4	8b7ef1464ea589886b575ebad5447b085cbdcdba
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SMG1 DST NAV3	6.46e-05	175	55	4	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RP1 CEP126 LGSN	6.60e-05	176	55	4	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DST ARMC3 ATRNL1 LOXL4	7.05e-05	179	55	4	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARMC3 PTCD2 LOXL3 ARHGAP8	7.21e-05	180	55	4	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARMC3 PTCD2 LOXL3 ARHGAP8	7.21e-05	180	55	4	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARMC3 RP1 CEP126 LGSN	7.36e-05	181	55	4	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	ARFGEF3 KIAA1217 RP1 LGSN	7.36e-05	181	55	4	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARFGEF3 KIAA1217 RP1 LRP1B	7.52e-05	182	55	4	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DST CECR2 RP1 LRP1B	7.52e-05	182	55	4	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 RP1 CEP126 LRRC9	7.52e-05	182	55	4	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 SPTA1 NAV3 LRP1B	7.85e-05	184	55	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 SPTA1 NAV3 LRP1B	7.85e-05	184	55	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 SPTA1 NAV3 LRP1B	7.85e-05	184	55	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ARFGEF3 KIAA1217 RP1 ARHGAP8	8.01e-05	185	55	4	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARFGEF3 REG4 CEP126 LRP1B	8.01e-05	185	55	4	eb78614c4acf8d2ce7874d7e51e16997b76127ef
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARFGEF3 CECR2 KIAA1217 RP1	8.18e-05	186	55	4	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ARFGEF3 KIAA1217 RP1 ARHGAP8	8.52e-05	188	55	4	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 NAV3 RP1 CEP126	8.70e-05	189	55	4	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARFGEF3 CECR2 KIAA1217 RP1	9.06e-05	191	55	4	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1	9.25e-05	192	55	4	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARFGEF3 ARMC3 RP1 CEP126	9.43e-05	193	55	4	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	ARMC3 RP1 CEP126 LRRC9	9.82e-05	195	55	4	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	ARFGEF3 DST RP1 LRP1B	1.00e-04	196	55	4	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1	1.00e-04	196	55	4	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ARFGEF3 ARMC3 KIAA1217 RP1	1.00e-04	196	55	4	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma\|mLN / shred on region, Cell_type, and subtype	HMSD ARFGEF3 ASB9 CECR2	1.02e-04	197	55	4	a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	ARFGEF3 ARMC3 RP1 CEP126	1.02e-04	197	55	4	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RP1 CEP126 LGSN LRRC9	1.02e-04	197	55	4	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|mLN / Region, Cell class and subclass	HMSD ARFGEF3 ASB9 CECR2	1.02e-04	197	55	4	20822fce311326765b71337ce501ba44ea14f58f
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	ARMC3 RP1 CEP126 LRRC9	1.04e-04	198	55	4	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARFGEF3 SERPINB7 ARMC3 LRRC9	1.06e-04	199	55	4	8649c2380285a668782d75eb076ce548eed0911d
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARMC3 RP1 CEP126 LRRC9	1.08e-04	200	55	4	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARMC3 RP1 CEP126 LRRC9	1.08e-04	200	55	4	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARMC3 RP1 CEP126 LRRC9	1.08e-04	200	55	4	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	DST ATRNL1 CRB1	1.76e-04	88	55	3	5582fd7bac60c690ecd1f2aff1d446ccb69f79b9
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-3\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ARMC3 TACR2 LRRC9	2.65e-04	101	55	3	d0c004d66ba847588a78d5c5c85e82e9e94d0e30
ToppCell	VE-CD4-CD8_2\|VE / Condition, Cell_class and T cell subcluster	ANKRD30B CRB1 LRRC9	4.60e-04	122	55	3	6745035feaf807b6a6b9537ac9d5ee0e000196eb
ToppCell	21-Trachea-Immune-Immune\|Trachea / Age, Tissue, Lineage and Cell class	HMSD SERPINB7 LOXL4	6.05e-04	134	55	3	4f0465324cc5b443ebadb68aef63be79b74f6ff9
ToppCell	facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAG CRB1 LRRC9	6.87e-04	140	55	3	115bd770a9d5e6f007a9aa0eadf5dba46d500107
ToppCell	facs-Thymus-nan-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAG CRB1 LRRC9	6.87e-04	140	55	3	22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6
ToppCell	facs-Thymus-nan-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAG CRB1 LRRC9	6.87e-04	140	55	3	62d1ef8cb78618ed89cac7ec89d7f54de06a90c7
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC2 LRP1B CRB1	7.61e-04	145	55	3	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Ciliated_cells-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 CEP126 LRRC9	8.23e-04	149	55	3	6399c5a2f06d79f020dece252526f1c0c110d569
ToppCell	368C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANKFY1 LOXL3 ABCC2	8.23e-04	149	55	3	9286bc56ff2e245630537a0bda5f1a1e17be863a
ToppCell	368C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANKFY1 LOXL3 ABCC2	8.23e-04	149	55	3	f53151d9e5e724a61be0ee6a8c740d1990f28d5f
ToppCell	Ciliated_cells-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 RP1 LGSN	8.55e-04	151	55	3	9d03ce73af15ef40c592d19b36aff46bebc14c40
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARFGEF3 KIAA1217 LRP1B	8.72e-04	152	55	3	1b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 CEP126 LRRC9	9.06e-04	154	55	3	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 CEP126 LRRC9	9.06e-04	154	55	3	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Basal_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	LOXL4 LGSN LRP1B	9.23e-04	155	55	3	30accc72a6a914ae0c4d52b373ea1c9a98efbf22
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ARFGEF3 TINAG ARHGAP8	9.23e-04	155	55	3	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	DST KIAA1217 LRP1B	9.40e-04	156	55	3	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	HMSD SPTA1 PAPLN	9.40e-04	156	55	3	19472ef1642c2ad333aa3ce3675a25c6ab1d4556
ToppCell	Control-Lymphocyte-T_NK-dnT\|Control / Disease, Lineage and Cell Type	KIAA1217 GBP2 MPRIP	9.75e-04	158	55	3	7a2fad6426549d910834debfe5e102fe2ab5976d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TINAG ANKRD30B RP1	9.93e-04	159	55	3	c186bf05c61fac348cf41973827cced83fafd58a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 LRP1B CRB1	1.01e-03	160	55	3	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 LRP1B CRB1	1.01e-03	160	55	3	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPTA1 CDC25C CRB1	1.03e-03	161	55	3	8ec923c230a7a3cce5edf2a736b3a00d607c698a
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HMSD PTCD2 LGSN	1.03e-03	161	55	3	0d863d7d369391dd6148e1de6d6f8033dcb8fe0f
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARFGEF3 KIAA1217 RP1	1.05e-03	162	55	3	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	Ciliated_cells-A-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	RP1 CEP126 LGSN	1.07e-03	163	55	3	43194c6127df1ce3d29242f719645de3c11fd7c0
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 RP1 CEP126	1.09e-03	164	55	3	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OVGP1 CDC25C LRP1B	1.10e-03	165	55	3	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OVGP1 CDC25C LRP1B	1.10e-03	165	55	3	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	LPS-antiTNF-Epithelial_airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARFGEF3 SERPINB7 ARMC3	1.12e-03	166	55	3	eb942ed68677e55c46cb039046f45686d4062d7c
ToppCell	Basal_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	SERPINB7 KIAA1217 LOXL4	1.12e-03	166	55	3	23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GBP2 GATAD2B DOP1A	1.14e-03	167	55	3	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ATRNL1 PAPLN KRT37	1.16e-03	168	55	3	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	15-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	ARMC3 RP1 LGSN	1.18e-03	169	55	3	425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RP1 CEP126	1.18e-03	169	55	3	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	HMSD ATRNL1 CDC25C	1.18e-03	169	55	3	a949f547b53126a208819bade74a1ac9b2a36ea7
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 KAT6A FGD6	1.18e-03	169	55	3	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	HMSD ATRNL1 CDC25C	1.18e-03	169	55	3	195d5cd60d646ac6d40a3321b2f739917e7aef14
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ANKFY1 DST KAT6B	1.18e-03	169	55	3	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
Drug	cumene	PDK2 SPTA1 LOXL4 LOXL3	5.96e-06	49	55	4	CID000007406
Drug	Wang resin	DST SPTA1	1.72e-05	3	55	2	CID000070043
Drug	amiguanidine	LOXL4 LOXL3	5.70e-05	5	55	2	CID000364439
Drug	AC1L1CLB	SPTA1 LOXL4 TACR2 LOXL3	7.27e-05	92	55	4	CID000001951
Drug	1-benzyl-2-methyl-5-methoxytryptamine	LOXL4 LOXL3	8.54e-05	6	55	2	CID000009925
Drug	BU99006	LOXL4 LOXL3	8.54e-05	6	55	2	CID006603748
Drug	5-hydroxyisatin	LOXL4 LOXL3	8.54e-05	6	55	2	CID010352011
Drug	T 794	LOXL4 LOXL3	8.54e-05	6	55	2	CID003077680
Drug	NSD 2023	LOXL4 LOXL3	8.54e-05	6	55	2	CID000019831
Drug	1-PCPA	LOXL4 LOXL3	8.54e-05	6	55	2	CID000194548
Drug	N-cyclopropyl-5,6-dimethoxytryptamine	LOXL4 LOXL3	8.54e-05	6	55	2	CID000156277
Drug	N-cyclopropyl-6,7-dimethoxytryptamine	LOXL4 LOXL3	8.54e-05	6	55	2	CID000156278
Drug	N-cyclopropyl-alpha-methylbenzylamine	LOXL4 LOXL3	8.54e-05	6	55	2	CID000362778
Drug	Mctp	LOXL4 LOXL3 CDC25C	9.78e-05	37	55	3	CID000129268
Drug	almotriptan	DGCR2 LOXL4 LOXL3	1.06e-04	38	55	3	CID000123606
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A	WDR19 DGCR2 NAV3 FAM53B FGD6	1.18e-04	199	55	5	7311_DN
Drug	dimethylphenethylamine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000025124
Drug	BU 224	LOXL4 LOXL3	1.19e-04	7	55	2	CID000002457
Drug	M 2113	LOXL4 LOXL3	1.19e-04	7	55	2	CID000072895
Drug	N-(2-aminoethyl)benzamide	LOXL4 LOXL3	1.19e-04	7	55	2	CID000423156
Drug	cimoxatone	LOXL4 LOXL3	1.19e-04	7	55	2	CID000052542
Drug	iproclozide	LOXL4 LOXL3	1.19e-04	7	55	2	CID000019063
Drug	brofaromine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000044570
Drug	tetrahydroharmine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000159809
Drug	4'-amino-MPTP	LOXL4 LOXL3	1.19e-04	7	55	2	CID000086263
Drug	4-methoxytranylcypromine	LOXL4 LOXL3	1.19e-04	7	55	2	CID003082143
Drug	1-Phenylcyclobutylamine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000152214
Drug	JB 835	LOXL4 LOXL3	1.19e-04	7	55	2	CID000152988
Drug	1-benzylcyclopropylamine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000152923
Drug	RS-2232	LOXL4 LOXL3	1.19e-04	7	55	2	CID000134882
Drug	SR 95191	LOXL4 LOXL3	1.19e-04	7	55	2	CID000072119
Drug	p-dimethylaminomethylbenzylamine	LOXL4 LOXL3	1.19e-04	7	55	2	CID000193714
Drug	MPTP-3-ol	LOXL4 LOXL3	1.19e-04	7	55	2	CID000100194
Drug	AC1O5VTH	LOXL4 LOXL3	1.59e-04	8	55	2	CID006441710
Drug	AC1Q6B1A	LOXL4 LOXL3	1.59e-04	8	55	2	CID000088562
Drug	4-chlorobenzylamine	LOXL4 LOXL3	1.59e-04	8	55	2	CID000066036
Drug	amezinium	LOXL4 LOXL3	1.59e-04	8	55	2	CID000071926
Drug	mebanazine	LOXL4 LOXL3	1.59e-04	8	55	2	CID000006179
Drug	mofegiline	LOXL4 LOXL3	1.59e-04	8	55	2	CID006437850
Drug	pyrazidol	LOXL4 LOXL3	1.59e-04	8	55	2	CID000068802
Drug	4-fluorotranylcypromine	LOXL4 LOXL3	1.59e-04	8	55	2	CID003082666
Drug	ranbezolid	LOXL4 LOXL3	1.59e-04	8	55	2	CID000496993
Drug	2-propyl-pentylamine	LOXL4 LOXL3	1.59e-04	8	55	2	CID000170419
Drug	AC1LCVO8	KAT6A KAT6B	1.59e-04	8	55	2	CID000656891
Drug	Q 192	LOXL4 LOXL3	1.59e-04	8	55	2	CID000077317
Drug	Lilly 51641	LOXL4 LOXL3	2.04e-04	9	55	2	CID000021485
Drug	3-amino-2-oxazolidinone	LOXL4 LOXL3	2.04e-04	9	55	2	CID000065725
Drug	toloxatone	LOXL4 LOXL3	2.04e-04	9	55	2	CID000034521
Drug	MDL 72392	LOXL4 LOXL3	2.04e-04	9	55	2	CID006439254
Drug	AC1L4KA6	LOXL4 LOXL3	2.04e-04	9	55	2	CID000158620
Drug	AC1L1BMC	LOXL4 LOXL3	2.04e-04	9	55	2	CID000001500
Drug	FLA 336	LOXL4 LOXL3	2.04e-04	9	55	2	CID000123706
Drug	RS-8359	LOXL4 LOXL3	2.04e-04	9	55	2	CID000164116
Drug	pinoline	LOXL4 LOXL3	2.04e-04	9	55	2	CID000001868
Drug	Ro 16-6491	LOXL4 LOXL3	2.04e-04	9	55	2	CID000004289
Drug	FLA 365	LOXL4 LOXL3	2.04e-04	9	55	2	CID000072776
Drug	J 508	LOXL4 LOXL3	2.04e-04	9	55	2	CID000155219
Drug	EXP 561	LOXL4 LOXL3	2.55e-04	10	55	2	CID000027696
Drug	U-0521	LOXL4 LOXL3	2.55e-04	10	55	2	CID000021632
Drug	acetylcadaverine	LOXL4 LOXL3	2.55e-04	10	55	2	CID000189087
Drug	Monase	LOXL4 LOXL3	2.55e-04	10	55	2	CID000008366
Drug	3-dimethylamino-1-propyne	LOXL4 LOXL3	2.55e-04	10	55	2	CID000081643
Drug	N-cyclopropylbenzylamine	LOXL4 LOXL3	2.55e-04	10	55	2	CID000025866
Drug	safrazine	LOXL4 LOXL3	2.55e-04	10	55	2	CID000034041
Drug	NmiQ	LOXL4 LOXL3	2.55e-04	10	55	2	CID000019850
Drug	NSC-169892	LOXL4 LOXL3	2.55e-04	10	55	2	CID000043479
Drug	befloxatone	LOXL4 LOXL3	3.11e-04	11	55	2	CID000060824
Drug	4-hydroxy-3-methoxyphenylglycol-piperazine	LOXL4 LOXL3	3.11e-04	11	55	2	CID002723890
Drug	NSC55260	LOXL4 LOXL3	3.11e-04	11	55	2	CID005356351
Drug	C04424	KAT6A KAT6B	3.11e-04	11	55	2	CID011953835
Drug	Amiflamina	LOXL4 LOXL3	3.11e-04	11	55	2	CID000071221
Drug	Sp 1 (pharmaceutical)	DGCR2 KAT6A LOXL4 LOXL3 KAT6B LRP1B SMG6	3.36e-04	548	55	7	CID000099040
Drug	MHPG	DGCR2 LOXL4 LOXL3	3.56e-04	57	55	3	CID000010805
Drug	FNPA	LOXL4 LOXL3	3.72e-04	12	55	2	CID000093121
Drug	anisylamine	LOXL4 LOXL3	3.72e-04	12	55	2	CID000075452
Drug	2-(2-benzofuranyl)-2-imidazoline	LOXL4 LOXL3	3.72e-04	12	55	2	CID003080926
Drug	AbeAdo	LOXL4 LOXL3	3.72e-04	12	55	2	CID006436013
Drug	kojic amine	LOXL4 LOXL3	3.72e-04	12	55	2	CID000003841
Drug	HLA20	LOXL4 LOXL3	3.72e-04	12	55	2	CID006918819
Drug	C05118	KAT6A KAT6B	3.72e-04	12	55	2	CID000440565
Drug	C05119	KAT6A KAT6B	3.72e-04	12	55	2	CID000440566
Drug	tylciprine	LOXL4 LOXL3	3.72e-04	12	55	2	CID000026069
Drug	pheniprazine	LOXL4 LOXL3	3.72e-04	12	55	2	CID000005929
Drug	viloxazine	LOXL4 LOXL3	3.72e-04	12	55	2	CID000005666
Drug	MPDP	LOXL4 LOXL3	3.72e-04	12	55	2	CID000150458
Drug	AC1L9EUB	KAT6A KAT6B	4.39e-04	13	55	2	CID000443527
Drug	SKF 64139	LOXL4 LOXL3	4.39e-04	13	55	2	CID000123919
Drug	isocarboxazid	LOXL4 LOXL3	5.12e-04	14	55	2	CID000003759
Drug	AC1L9EU8	KAT6A KAT6B	5.12e-04	14	55	2	CID000443526
Drug	kynuramine	LOXL4 LOXL3	5.12e-04	14	55	2	CID000009692
Drug	FMMT	LOXL4 LOXL3	5.12e-04	14	55	2	CID006438682
Drug	MDL 72145	LOXL4 LOXL3	5.12e-04	14	55	2	CID006438383
Drug	benzylhydrazine	LOXL4 LOXL3	5.12e-04	14	55	2	CID000011157
Drug	lazabemide	LOXL4 LOXL3	5.12e-04	14	55	2	CID000071307
Drug	AC1LCVO5	KAT6A KAT6B	5.12e-04	14	55	2	CID000656890
Drug	2'CH3-MPTP	LOXL4 LOXL3	5.12e-04	14	55	2	CID000091767
Disease	lower face morphology measurement	NAV3 LRP1B CRB1 SMG6	4.83e-05	109	54	4	EFO_0010948
Disease	lung non-small cell carcinoma (is_implicated_in)	TET2 ARID1B ABCC2 LRP1B	1.24e-04	139	54	4	DOID:3908 (is_implicated_in)
Disease	neutrophil count	TET2 ARMC3 PTCD2 FAM53B AKAP11 RP1 NSMCE2 ZMYM4 SMG6	8.36e-04	1382	54	9	EFO_0004833
Disease	diastolic blood pressure, systolic blood pressure	ARID1B ANKFY1 PTCD2 LOXL4 FAM53B CRB1	1.37e-03	670	54	6	EFO_0006335, EFO_0006336
Disease	Papillary Renal Cell Carcinoma	TET2 NAV3 LRP1B	1.68e-03	128	54	3	C1306837
Disease	Renal Cell Carcinoma	TET2 NAV3 LRP1B	1.68e-03	128	54	3	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	TET2 NAV3 LRP1B	1.68e-03	128	54	3	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TET2 NAV3 LRP1B	1.68e-03	128	54	3	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TET2 NAV3 LRP1B	1.68e-03	128	54	3	C1266044

Protein segments in the cluster

Peptide	Gene	Start	Entry
NMFAVHNSQLKDCFS	SMG6	946	Q86US8
ANANAFNESKCTALM	ANKRD30B	196	Q9BXX2
CLLMDFGADTQAKNA	ASB9	216	Q96DX5
SNSNFMASAKDANEN	C1orf216	31	Q8TAB5
LQCSEASSNKDMFAD	AKAP11	926	Q9UKA4
SDKHFMQNFACSNVS	DOP1A	1031	Q5JWR5
KAQEAAAAVMQAAAN	ARID1B	1011	Q8NFD5
SAMCENSGSKDFFNN	ARMC3	341	Q5W041
LFSDKNAMASLQGCE	CECR2	1256	Q9BXF3
KGCAFAQFMTQEAAQ	RBM28	376	Q9NW13
SSSQQLAQCSMAANF	KAT6B	1761	Q8WYB5
FSNNNLTKMEGLESC	LRRC9	916	Q6ZRR7
FACAMTFKNNKSAEA	ANKFY1	841	Q9P2R3
VAESDFTNNAMKCNC	LOXL3	701	P58215
AESDFSNNMLQCRCK	LOXL4	706	Q96JB6
MSAAKENPCRKFQAN	MPRIP	1	Q6WCQ1
SAEQSCNSSFFMCKN	LRP1B	2886	Q9NZR2
LEALMASNDNANKTC	DST	5221	Q03001
AEANAASMCLLANVA	KRT37	36	O76014
DLAKMAQNCQTFSSL	FAM53B	296	Q14153
MKLQEAANYSSTQSC	NAV3	2351	Q8IVL0
SLKNFQACINSGMDT	NSMCE2	26	Q96MF7
QNSKASSDCCMALLQ	GBP2	396	P32456
CNFDKAMQFSEASFT	ABCC2	631	Q92887
AMTDAANSQAAAKLA	GATAD2B	341	Q8WXI9
RDAMCSSSANKENDN	CDC25C	141	P30307
LSMKQFLDFGSSNAC	PDK2	31	Q15119
SSCRDQGKNADNMLF	KAT6A	266	Q92794
ANMQSTNLSCFDEDK	CEP126	286	Q9P2H0
AANCASALAQMAAAS	ARFGEF3	931	Q5TH69
CISANSNCSMSVKNY	ATRNL1	691	Q5VV63
FASAMSENDNVFCAQ	DGCR2	221	P98153
GNTAAQMSQALCFSK	HMSD	16	A8MTL9
CSDTANNLDKDCDNM	CRB1	56	P82279
SVNCMDNAEAQFTTA	MAU2	391	Q9Y6X3
ALADLCMAAFNAAFN	TACR2	76	P21452
KDNEMNNIRATCFNS	LGSN	131	Q5TDP6
SCFAVALALNQNEMA	PTCD2	241	Q8WV60
AFDMATNAACASLLK	OSTF1	176	Q92882
CTHLIFAFASMNNNQ	OVGP1	51	Q12889
NKHCAEMSSNNNFLT	REG4	126	Q9BYZ8
LNLKGSMNSFCQVDA	RP1	1136	P56715
SMNSFCQVDAHKATN	RP1	1141	P56715
KRCQQMCSFASQFNS	SMG1	3331	Q96Q15
QKCSFMDVNSNSHAE	KIAA1217	1141	Q5T5P2
MSKCNNEAFTLAQQH	WDR19	976	Q8NEZ3
ANNFASEQECMSSCQ	PAPLN	791	O95428
NSDAQDLVNSQKAMC	FGD6	391	Q6ZV73
MASLAAANAEFCFNL	SERPINB7	1	O75635
FGDSMKALRNQANAC	SPTA1	951	P02549
RESIFNKMNSSNLAC	ARHGAP8	361	P85298
NKMNSSNLACVFGLN	ARHGAP8	366	P85298
ACLSKFHSANNFIMN	ZMYM1	216	Q5SVZ6
KDQNATNNGCAMASR	TINAG	311	Q9UJW2
MMATANENLSAKFCN	UBR4	1411	Q5T4S7
ADNASKLAAMLNTCS	TET2	301	Q6N021
CFSKFRSANNLTMNC	ZMYM4	471	Q5VZL5